GE HealthCare Technologies Inc. which can be found using ticker (GEHC) have now 10 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 99 and 78 suggesting an average Analsyt target price of $88.00. Given that the stocks previous close was at $68.19 this is indicating there is a potential upside of 29.1%. It’s also worth noting that there is a 50 day moving average of $68.82 and the 200 day MA is $73.95. The company has a market capitalization of 30.83B. The current share price for the company is: 67.78 USD
The potential market cap would be $39,785,086,277 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 18.78, revenue per share of 41.86 and a 5.77% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
